Xtrapharma SRL
The score of Xtrapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +49 % Total assets +48 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Xtrapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 142,634 € | ||||
| Equity | 839,344 € | ||||
| Cash | 266,028 € | ||||
| EBITDA | 225,072 € | ||||
| Total assets | €2.17m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 25 Nov 2025
- Year ended 31 Dec 2023filed on 20 Nov 2025
- Year ended 31 Dec 2022filed on 31 Oct 2023
- Year ended 31 Dec 2021filed on 10 Feb 2023
Xtrapharma's financial analysis
- Solvency38.7%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Xtrapharma
Xtrapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0751.561.839
- VAT number
- BE0751561839
- Peppol
- Registered · 0208:0751561839 · as of 28 Oct 2026
- Legal form
- SRL
- Incorporated
- 28 Jul 2020
- Registered office
- 1130 Brussels
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Xtrapharma (SRL) has been based in Brussels since 2020, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 142,634 € and equity of 839,344 €; its revenue is not published. Its solvency stands at 38.7%, above the median of its sector (32.3%).
Companies similar to Xtrapharma
Companies in the same business, of comparable size and area, outside its group.
- Corza Medical Activities of agents involved in the wholesale of other particular products Machelen (Brab.) · balance sheet €1.35m
- Accuray Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 257,954 €
- Esteve Pharmaceuticals Wholesale of pharmaceutical and medical goods Jette · balance sheet €2.91m
- Adhoc Medical Wholesale of pharmaceutical and medical goods Verviers · balance sheet €1.69m
- DHCare Belgium Wholesale of pharmaceutical and medical goods Zedelgem · balance sheet €2.81m
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- G-Flex Flexible Instruments Europe Wholesale of pharmaceutical and medical goods Nivelles · balance sheet €3.68m
- Impexeco Wholesale of pharmaceutical and medical goods Mouscron · balance sheet €3.83m
Frequently asked questions about Xtrapharma
What is the revenue of Xtrapharma?
Xtrapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Xtrapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0751561839 for Xtrapharma, if the company is VAT-registered. Its company number (CBE) is 0751.561.839.
Where is the registered office of Xtrapharma?
According to the CBE register, the registered office of Xtrapharma is in 1130 Brussels.
What is the equity of Xtrapharma?
At the close of the 2025 financial year, the equity of Xtrapharma amounts to 839,344 €, a solvency of 38.7% of total assets.
Who manages Xtrapharma?
The register lists 1 active mandates at Xtrapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Xtrapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →